In addition, WISP2 likely plays a preventive role in the progression of pancreatic cancer by participating in morphological alterations from mesenchymal to epithelial transition (MET) of pancreatic adenocarcinoma [12] and breast cancer cells [18]. Here, CCN5 is linked to breast carcinoma.